(Reuters) - The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary ...
GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of ...
GE HealthCare has received approval for Flyrcado, its enhanced diagnosis tool for coronary heart disease, from the Food and Drug Administration. The company said on Friday that Flyrcado, or ...
Micron stock surges after strong earnings and guidance, fellow chip makers such as Nvidia and ASML rally, Southwest Airlines ...
GE HealthCare (Nasdaq: GEHC) today announced its latest innovations in radiation oncology that will be showcased at the ...
GE HealthCare’s recently acquired MIM Software division has secured an FDA clearance for a tool to help quantify the density ...
Hippocratic AI is developing a generative AI model that aims to help providers complete non-diagnostic and patient-facing ...
In a report released yesterday, Ryan Zimmerman from BTIG upgraded GE Healthcare Technologies Inc (GEHC – Research Report) to a Buy, with ...
The GE HealthCare imaging tool is coming out as pharma companies release new therapies onto the market to help treat the ...
GE HealthCare (GEHC) was cut to sell by UBS on Thursday, with the bank asserting that risks such as increasing Chinese ...
Selvan Senthivel is the new chief technology officer for the 6-year-old Seattle startup. Senthivel was most recently CTO for ...